Understanding the extent of economic evidence usage for informing policy decisions in the context of India’s national health insurance scheme: Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana (PM-JAY)
Open Access
- 10 June 2024
- journal article
- research article
- Published by BMJ in BMJ Global Health
- Vol. 9 (6) , e015079
Abstract
Introduction Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana (PM-JAY) is one of the world’s largest tax-funded insurance schemes. The present study was conducted to understand the decision-making process around the evolution (and revision) of health benefit packages (HBPs) and reimbursement rates within PM-JAY, with a specific focus on assessing the extent of use of economic evidence and role of various stakeholders in shaping these policy decisions. Methods A mixed-methods study was adopted involving in-depth interviews with seven key stakeholders involved in HBP design and reimbursement rates decisions, and a survey of 80 government staff and other relevant stakeholders engaged in the implementation of PM-JAY. The data gathered were thematically analysed, and a coding framework was developed to explore specific themes. Additionally, publicly available documents were reviewed to ensure a comprehensive understanding of the decision-making processes. Results Findings reveal a progressive transition towards evidence-based practices for policy decisions within PM-JAY. The initial version of HBP relied heavily on key criteria like disease burden, utilisation rates, and out-of-pocket expenditures, along with clinical opinion in shaping decisions around the inclusion of services in the HBP and setting reimbursement rates. Revised HBPs were informed based on evidence from a national-level costing study and broader stakeholder consultations. The use of health economic evidence increased with each additional revision with consideration of health technology assessment (HTA) evidence for some packages and reimbursement rates based on empirical cost evidence in the most recent update. The establishment of the Health Financing and Technology Assessment unit further signifies the use of evidence-based policymaking within PM-JAY. However, challenges persist, notably with regard to staff capacity and understanding of HTA principles, necessitating ongoing education and training initiatives. Conclusion While substantial progress has been made in transitioning towards evidence-based practices within PM-JAY, sustained efforts and political commitment are required for the ongoing systematisation of processes.Keywords
Funding Information
- Bill & Melinda Gates Foundation (INV-003239)
This publication has 27 references indexed in Scilit:
- Social Health Protection and Publicly Funded Health Insurance Schemes in India: The Right Way Forward?The Indian Journal of Labour Economics, 2023
- Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 CountriesPharmacoEconomics - Open, 2021
- Health Technology Assessment in Australia: The Pharmaceutical Benefits Advisory Committee and Medical Services Advisory CommitteeValue in Health Regional Issues, 2021
- Translating Research to Policy: Setting Provider Payment Rates for Strategic Purchasing under India's National Publicly Financed Health Insurance SchemeApplied Health Economics and Health Policy, 2021
- Penetration and coverage of government-funded health insurance schemes in IndiaClinical Epidemiology and Global Health, 2020
- Addressing the Cost Data Gap for Universal Healthcare Coverage in India: A Call to ActionValue in Health Regional Issues, 2020
- Health Technology Assessment for Policy Making in India: Current Scenario and Way ForwardPharmacoEconomics - Open, 2017
- Health technology assessments in England: an analysis of the NICE Medical Technologies Evaluation ProgrammeThe European Journal of Health Economics, 2013
- Economic evaluation to inform health care decision-making: Promise, pitfalls and a proposal for an alternative pathSocial Science & Medicine, 2011
- Defining the “Health Benefit Basket” in nine European countriesThe European Journal of Health Economics, 2005